Tadalafil oral film - MonoSol Rx

Drug Profile

Tadalafil oral film - MonoSol Rx

Alternative Names: Tadalafil PharmFilm

Latest Information Update: 09 Feb 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator MonoSol Rx
  • Class Benzodioxoles; Carbolines; Erectile dysfunction therapies; Indoles; Small molecules
  • Mechanism of Action Type 5 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Erectile dysfunction

Highest Development Phases

  • Preregistration Erectile dysfunction

Most Recent Events

  • 07 Feb 2017 Planned Prescription Drug User Fee Act (PDUFA) date for Erectile dysfunction in USA (PO) is 2017-09-18
  • 07 Feb 2017 The US FDA accepts NDA for tadalafil oral soluble film for Erectile dysfunction for review
  • 28 Nov 2016 Preregistration for Erectile dysfunction in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top